Please login to the form below

Ebola virus

This page shows the latest Ebola virus news and features for those working in and with pharma, biotech and healthcare.

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

This includes Gilead’s investigational antiviral drug remdesivir, which the company had originally been evaluating as a treatment for Ebola virus disease. ... Unfortunately, not all efforts to repurpose drugs have proved successful, with AbbVie’s

Latest news

J&J says COVID-19 vaccine could be ready in early 2021

which have already been deployed to make vaccines for Ebola, Zika, HIV and respiratory syncytial virus (RSV) candidates. ... During the Ebola virus epidemic in West Africa, J&J’s Janssen unit used the platforms to produce more than two million vaccine
UPDATED: Gilead drops remdesivir’s orphan drug designation

It added that it is “making significant at-risk investments to develop and manufacture” the drug as the virus spreads at a rapid rate not only in the US, but across ... Remdesivir, originally developed as a treatment for Ebola virus disease, has been
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

The drug, which health experts from the World Health Organization (WHO) said is one of the most promising candidates against the virus, is currently being studied across two trials in China, ... Prior to the novel coronavirus outbreak, Gilead was
Moderna and GSK advance coronavirus vaccine candidates

Aside from vaccines, Gilead has offered its investigational antiviral drug remdesivir for clinical trials in China – the drug has been identified as showing promise against the virus, and will be evaluated ... The drug was originally being developed as
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir

The one with the most potential – so far – has been antiviral drug remdesivir, which Gilead had already been developing as a treatment for Ebola disease and Marbug virus infections. ... The Friendship Hospital will study 761 patients with COVID-19 in

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest Intelligence

COVID-19: the race to find a vaccine

Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus. ... The same platform underpins CanSino’s Ebola vaccine that won approval in China in 2017.
As COVID-19 takes over the world, biopharma fights back

Prior to the coronavirus outbreak, Gilead had primarily been focused on testing remdesivir’s potential in Ebola virus disease, although the antiviral also demonstrated promise in other coronaviruses, including severe acute ... This is particularity
Communicating in a crisis

Nobody working in the healthcare world has been able to ignore the outbreak of the Ebola virus in West Africa this past year. ... Timeline of Ebola outbreak in West Africa. December 2013. Two-year-old child contracts Ebola virus in Guinea.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

IFPMA elects Pfizer’s Ian Read as president

focus on the industry's efforts to develop treatments for the recent Ebola and Zika virus outbreaks.
Sanofi names CSO Gary Nabel to Ebola role

Concerning the role, Nabel said: “Working with out colleagues across the industry, Sanofi is helping to find ways to advance medicines to prevent or treat Ebola virus infection. ... an Ebola vaccine at NIH, Dr Nabel is uniquely qualified for this

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Cool heads in a crisis?

First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...